International Business Machines Corporation vs VeriSign, Inc.: Strategic Focus on R&D Spending

IBM vs. VeriSign: A Decade of R&D Investment

__timestampInternational Business Machines CorporationVeriSign, Inc.
Wednesday, January 1, 2014543700000067777000
Thursday, January 1, 2015524700000063718000
Friday, January 1, 2016572600000059100000
Sunday, January 1, 2017559000000052342000
Monday, January 1, 2018537900000057884000
Tuesday, January 1, 2019591000000060805000
Wednesday, January 1, 2020626200000074671000
Friday, January 1, 2021648800000080529000
Saturday, January 1, 2022656700000085700000
Sunday, January 1, 2023677500000091000000
Monday, January 1, 2024096700000
Loading chart...

Unleashing the power of data

Strategic Focus on R&D: IBM vs. VeriSign

In the ever-evolving tech landscape, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, International Business Machines Corporation (IBM) has consistently outpaced VeriSign, Inc. in R&D investment. From 2014 to 2023, IBM's R&D expenses grew by approximately 25%, peaking at $6.8 billion in 2023. In contrast, VeriSign's R&D spending increased by about 34% over the same period, reaching $91 million in 2023. Despite the smaller absolute figures, VeriSign's growth rate highlights its strategic focus on enhancing its technological capabilities. However, the data for 2024 is incomplete, indicating a potential shift or pause in these trends. This analysis underscores the importance of R&D in maintaining competitive advantage and driving future growth in the tech industry.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
28 Jan 2025